- Home
- OXSQ vs CGTX Comparison
OXSQ vs CGTX Comparison
Compare OXSQ & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OXSQ | CGTX |
|---|---|---|
| Founded | 2003 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 158.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | OXSQ | CGTX |
|---|---|---|
| Price | $1.78 | $1.53 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $2.88 |
| AVG Volume (30 Days) | 788.1K | ★ 963.1K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 23.46% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $40,142,565.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.27 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.56 | $0.22 |
| 52 Week High | $2.87 | $3.83 |
Technical Indicators
Market Signals| Indicator | OXSQ | CGTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.22 | 44.88 |
| Support Level | $1.82 | $1.46 |
| Resistance Level | $1.87 | $1.76 |
| Average True Range (ATR) | 0.04 | 0.12 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 16.83 | 17.14 |
Price Performance
Historical ComparisonAbout OXSQ Oxford Square Capital Corp.
Oxford Square Capital Corp is a closed-end, non-diversified management investment company with a focus is to seek an attractive risk-adjusted total return by investing in corporate debt securities and collateralized loan obligation (CLO) structured finance investments that own corporate debt securities. its capital is generally used by its corporate borrowers to finance organic growth, acquisitions, recapitalizations, and working capital. The group invests in various industries such as Structured Finance, IT Consulting, Business Services, Utilities, Software, Healthcare, Telecommunication Services, Plastics Manufacturing and Diversified Insurance.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.